Naltrexone (Naltraccord) tab 50 mg: Supply issue resolved
Teva, the supplier of naltrexone hydrochloride tab 50 mg Naltraccord (Pharmacode 2380374), had an out of stock of this product.
14 March 2025 | Update
The Medsafe-approved product has arrived and been released to wholesalers. It may take another one to two weeks to reach pharmacies around the motu.
Affected product
- Chemical: Naltrexone hydrochloride
- Presentation: Tab 50 mg
- Brand: Naltraccord
- Pharmacode: 2380374
- Subsidy: $83.33
- Measure / Qty: per 30
Schedule listing for naltrexone(external link)
Alternative product
Teva found an alternative, Naltrexone Max Health. It was not Medsafe registered, so had to be prescribed and dispensed in line with section 29 of the Medicines Act.
- Chemical: naltrexone hydrochloride
- Brand: Naltrexone Max Health
- Presentation: 50 mg tablet
- Pharmacode: 2692961
- Price: $102.60
- Pack size: 30
- Section 29 wastage and claimable rules apply
We listed the Revia brand (2689049) as an alternative. Unfortunately, stock could not arrive in time to support this supply issue.
Prescribing and supplying an unapproved medicine
Section 29 of the Medicines Act 1981 allows for medicines that are not Medsafe approved to be prescribed and supplied to people. The medicine must be prescribed by someone registered with the Medical Council of New Zealand – such as, a doctor.
We know supplying a medicine under section 29 is not ideal. In this case, however, this will allow patients to be able to access an appropriate treatment.
We apologise for any inconvenience this causes.
Advice for prescribing under section 29 – BPAC website(external link)
Prescriber and pharmacist requirements for section 29 medicines – Medsafe website (external link)
Medsafe’s section 29 Declaration / Notification Form [DOC](external link)
What patients need to know about unapproved medicines – Healthify website(external link)
Resupplied mid-March 2025
The registered stock has arrived and been sent to wholesalers. It may take another one to two weeks to reach pharmacies around the motu.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)